| Kristen D Bruce, DO | |
|
3130 N County Road 25a # 112, Troy, OH 45373-1337 | |
| (937) 440-4000 | |
| Not Available |
| Full Name | Kristen D Bruce |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 3130 N County Road 25a # 112, Troy, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487283628 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 34.016820 (Ohio) | Secondary |
| 207R00000X | Internal Medicine | 34.016820 (Ohio) | Primary |
| Entity Name | Mvhe Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659504785 PECOS PAC ID: 9537066584 Enrollment ID: O20031217000553 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a drug's effect on reduction of new hip fractures is the attribute that most influences U.S. and European surveyed primary care physicians' (PCPs') prescribing decisions in osteoporosis.
Adding another reason for people to watch their blood pressure, a new study from North Carolina State University shows that increased blood pressure in older adults is directly related to decreased cognitive functioning, particularly among seniors with already high blood pressure.
In this post on the PLoS "Speaking of Medicine" blog, Grania Brigden, the tuberculosis adviser to the Medecins Sans Frontieres Campaign for Access to Essential Medicines, writes that while "[t]his year's Global Tuberculosis Control report shows the beginning of a decline in the global tuberculosis epidemic, ... there is a stark lack of data for children," continuing, "Without a clear estimate of the magnitude of the problem it is hard to motivate governments, researchers and donors."
America's biopharmaceutical research companies are intensifying research into rare diseases, which often are among the most devastating to patients and complex for researchers. A record 460 medicines for rare diseases are in late stages of the pipeline, either in clinical trials or awaiting Food and Drug Administration (FDA) review, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 3 days ago
| Entity Name | Upper Valley Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407872518 PECOS PAC ID: 5597658138 Enrollment ID: O20040206000038 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a drug's effect on reduction of new hip fractures is the attribute that most influences U.S. and European surveyed primary care physicians' (PCPs') prescribing decisions in osteoporosis.
Adding another reason for people to watch their blood pressure, a new study from North Carolina State University shows that increased blood pressure in older adults is directly related to decreased cognitive functioning, particularly among seniors with already high blood pressure.
In this post on the PLoS "Speaking of Medicine" blog, Grania Brigden, the tuberculosis adviser to the Medecins Sans Frontieres Campaign for Access to Essential Medicines, writes that while "[t]his year's Global Tuberculosis Control report shows the beginning of a decline in the global tuberculosis epidemic, ... there is a stark lack of data for children," continuing, "Without a clear estimate of the magnitude of the problem it is hard to motivate governments, researchers and donors."
America's biopharmaceutical research companies are intensifying research into rare diseases, which often are among the most devastating to patients and complex for researchers. A record 460 medicines for rare diseases are in late stages of the pipeline, either in clinical trials or awaiting Food and Drug Administration (FDA) review, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen D Bruce, DO 3130 N County Road 25a # 112, Troy, OH 45373-1337 Ph: () - | Kristen D Bruce, DO 3130 N County Road 25a # 112, Troy, OH 45373-1337 Ph: (937) 440-4000 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a drug's effect on reduction of new hip fractures is the attribute that most influences U.S. and European surveyed primary care physicians' (PCPs') prescribing decisions in osteoporosis.
Adding another reason for people to watch their blood pressure, a new study from North Carolina State University shows that increased blood pressure in older adults is directly related to decreased cognitive functioning, particularly among seniors with already high blood pressure.
In this post on the PLoS "Speaking of Medicine" blog, Grania Brigden, the tuberculosis adviser to the Medecins Sans Frontieres Campaign for Access to Essential Medicines, writes that while "[t]his year's Global Tuberculosis Control report shows the beginning of a decline in the global tuberculosis epidemic, ... there is a stark lack of data for children," continuing, "Without a clear estimate of the magnitude of the problem it is hard to motivate governments, researchers and donors."
America's biopharmaceutical research companies are intensifying research into rare diseases, which often are among the most devastating to patients and complex for researchers. A record 460 medicines for rare diseases are in late stages of the pipeline, either in clinical trials or awaiting Food and Drug Administration (FDA) review, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
› Verified 3 days ago
Mr. Pradip Mahendrabhai Vyas, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 S Stanfield Rd, Troy, OH 45373 Phone: 937-335-0665 Fax: 937-339-3652 | |
Dr. Bryan Jenkins King, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3006 N County Road 25a Ste 104, Troy, OH 45373 Phone: 937-335-3518 Fax: 937-332-6857 | |
Fraol Meskele Adugna, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3130 N County Road 25a, Troy, OH 45373 Phone: 937-440-4466 Fax: 937-440-4470 | |
Scott W Swabb, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3006 N County Road 25a Ste 106, Troy, OH 45373 Phone: 937-778-1000 Fax: 937-440-4275 | |
Dr. Jonathan Lafond, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3130 N County Road 25a, Troy, OH 45373 Phone: 937-440-4000 | |
Dr. Suzette K Millington-buffong, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W Main St, Troy, OH 45373 Phone: 937-980-7400 | |
Dr. Gbeminiyi Olanrewaju Samuel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3130 N County Road 25a Ste 109, Troy, OH 45373 Phone: 937-440-9292 Fax: 937-440-4227 |